1 | 20 mg | - | - | - | - | [1] 97 97 |
2 | 20 mg BID of PF-02545920 | - | - | - | - | [1] 8 8 |
3 | 20 mg fampridine-SR (4-aminopyridine, 4-AP) | [1] Dalfampridine Dalfampridine | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
4 | 20 mg GA | - | - | - | - | [1] 13 13 |
5 | 20 mg MitoQ | - | - | - | - | [1] 13 13 |
6 | 20 mg sildenafil citrate by mouth | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
7 | 20 mg/ml Treprostinil | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
8 | ACOMPLIA 20 mg film-coated tablets | [1] Rimonabant Rimonabant | [1] D05731
D05731
| [1] CNR1 CNR1 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 193 193 |
9 | ADCIRCA 20 mg film-coated tablets | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
10 | Apremilast 20 mg | [1] Apremilast Apremilast | [1] D08860
D08860
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [3] 46 46, 56, 107 |
11 | Apremilast tablet 20 mg | [1] Apremilast Apremilast | [1] D08860
D08860
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 271 271 |
12 | Arava 20 mg filmdrasjerte tabletter | - | - | - | - | [1] 46 46 |
13 | Arava 20 mg Tablets (Aventis Pharmaceutical, Inc.) | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 46 46 |
14 | ARC1905 20 MG/ML | - | - | - | - | [1] 301 301 |
15 | ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA | [1] Ofatumumab Ofatumumab | [1] D09314
D09314
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
16 | Atorvastatin tablet 20 mg | [1] Atorvastatin Atorvastatin | [1] D07474
D07474
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 46 46 |
17 | Avatrombopag 20 MG | [1] Avatrombopag Avatrombopag | [1] D10306
D10306
| [1] MPL MPL 💬 | [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 60 60 |
18 | Avatrombopag 20 MG Oral Tablet | [1] Avatrombopag Avatrombopag | [1] D10306
D10306
| [1] MPL MPL 💬 | [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 60 60 |
19 | AZD9567 20 mg | - | - | - | - | [1] 46 46 |
20 | Baclofen 20 mg | [1] Baclofen Baclofen | [1] D00241
D00241
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
21 | Baclofen ER Capsules (GRS) 20 mg | [1] Baclofen Baclofen | [1] D00241
D00241
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
22 | Bardoxolone methyl 20 mg | [2] Bardoxolone Bardoxolone, Bardoxolone methyl | [2] D09584
D09584
,
D09585
| - | - | [1] 67 67 |
23 | Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour UDCA therapy | [2] Bezafibrate Bezafibrate, Ursodeoxycholic acid | [2] D00734
D00734
,
D01366
| [2] NR1H4 NR1H4, PPARA 💬 | [11] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 94 94 |
24 | BF 2.649 20 mg | - | - | - | - | [1] 6 6 |
25 | BIBR 796 BS, 20 mg | - | - | - | - | [1] 96 96 |
26 | BTT1023 IV Infusion 20 mg/mL, 5 mL Drug Product | - | - | - | - | [1] 94 94 |
27 | Carbidopa 20 mg | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
28 | Chronocort® 20 mg | - | - | - | - | [1] 81 81 |
29 | CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 75 75 |
30 | CIALIS 20 mg comprimidos recubiertos con película | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
31 | Cialis 20 mg film-coated tablets | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 86 86, 113 |
32 | CK-3773274 (5 - 20 mg) | - | - | - | - | [1] 58 58 |
33 | CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg) | - | - | - | - | [1] 58 58 |
34 | COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
35 | COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
36 | Copaxone 20 mg | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
37 | Copaxone 20 mg/ml | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
38 | COPAXONE 20 mg/ml solución inyectable en jeringa precargada | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
39 | Copaxone 20 mg/ml solución para inyección en jeringa precargada | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
40 | Copaxone 20 mg/ml Solution for Injection, pre-filled syringe | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
41 | Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes | [1] Glatiramer Glatiramer | - | - | - | [1] 13 13 |
42 | CORTANCYL 20 mg | [1] Prednisone acetate Prednisone acetate | [1] D08416
D08416
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 35 35, 162 |
43 | Cortancyl ® 20 mg | [1] Prednisone acetate Prednisone acetate | [1] D08416
D08416
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 |
44 | Decortin 20 mg | - | - | - | - | [1] 96 96 |
45 | Dexamethasone Oral, 20 mg | [1] Dexamethasone Dexamethasone | [1] D00292
D00292
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 28 28 |
46 | Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg | [3] Dextromethorphan Dextromethorphan, Quinidine, Sulfate ion | [2] D03742
D03742
,
D08458
| [11] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | [22] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [2] 2 2, 13 |
47 | Doptelet 20 mg film-coated tablets | [1] Avatrombopag Avatrombopag | [1] D10306
D10306
| [1] MPL MPL 💬 | [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 63 63 |
48 | Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
49 | Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
50 | Ebetrex 15 mg = 0,75 ml, oplossing voor injectie in voorgevulde injectiespuit 20 mg/ml | - | - | - | - | [1] 96 96 |
51 | Efgartigimod concentrate for solution for infusion 20 mg/mL | - | - | - | - | [1] 11 11 |
52 | Encapsulated Baclofen 20 mg | [1] Baclofen Baclofen | [1] D00241
D00241
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
53 | Esomeprazole 20 mg | [1] Esomeprazole Esomeprazole | [1] D07917
D07917
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 46 46 |
54 | Famotidine 20 MG | [1] Famotidine Famotidine (Synonym: Riva-famotidine 20 mg) | [1] D00318
D00318
| [1] HRH2 HRH2 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | [1] 86 86 |
55 | GA 20 mg/mL | - | - | - | - | [1] 13 13 |
56 | Glatiramer acetate 20 mg | [2] Acetate Acetate, Glatiramer | - | - | - | [1] 13 13 |
57 | Glatiramer acetate 20 mg, with mitoxantrone | [3] Acetate Acetate, Glatiramer, Mitoxantrone | [1] D08224
D08224
| [2] TOP2A TOP2A, TOP2B 💬 | [1] Platinum drug resistance Platinum drug resistance 💬 | [1] 13 13 |
58 | Glatiramer Acetate 20 mg/0.5 mL | [2] Acetate Acetate, Glatiramer | - | - | - | [1] 13 13 |
59 | GWP42003-P 20 mg/kg/day Dose | - | - | - | - | [2] 140 140, 144 |
60 | Humira 20 mg solution for injection in pre-filled syringe | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
61 | Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL) | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
62 | Infliximab 20 mg/kg | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
63 | IPX056 20 mg | - | - | - | - | [1] 13 13 |
64 | IPX056-20 mg | - | - | - | - | [1] 13 13 |
65 | Isosorbide Dinitrate 20 mg | [2] Isosorbide Isosorbide, Isosorbide dinitrate | [2] D00347
D00347
,
D00516
| - | - | [1] 113 113 |
66 | Istradefylline 20 mg | [1] Istradefylline Istradefylline | [1] D04641
D04641
| [1] ADORA2A ADORA2A 💬 | [7] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 |
67 | Istradefylline 20 mg or 40 mg | [1] Istradefylline Istradefylline | [1] D04641
D04641
| [1] ADORA2A ADORA2A 💬 | [7] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 |
68 | Kesimpta 20 mg Injektionslösung im Fertigpen | [1] Ofatumumab Ofatumumab | [1] D09314
D09314
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
69 | Kesimpta 20 mg solution for injection in pre-filled pen | [1] Ofatumumab Ofatumumab | [1] D09314
D09314
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
70 | LCI699, 20 mg | - | - | - | - | [1] 75 75 |
71 | Leflunomide 20 mg Tablets (Geneva Pharmaceutical) | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 46 46 |
72 | Leflunomide 20 mg+prednisone 0.5mg/kg/d | [2] Leflunomide Leflunomide, Prednisone | [2] D00473
D00473
,
D00749
| [2] DHODH DHODH, NR3C1 💬 | [4] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬 | [1] 66 66 |
73 | Lenabasum 20 mg | - | - | - | - | [2] 51 51, 299 |
74 | Lenabasum 20 mg Powder in Capsule | - | - | - | - | [1] 51 51 |
75 | Lojuxta 20 mg hard capsules | [1] Lomitapide Lomitapide | [1] D09637
D09637
| [1] MTTP MTTP 💬 | [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 |
76 | Losec Capsules 20 mg | [1] Omeprazole Omeprazole (Synonym: Omeprazole 20 mg) | [1] D00455
D00455
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 46 46 |
77 | LY3337641 20 mg | - | - | - | - | [1] 46 46 |
78 | MBS2320 20 mg | - | - | - | - | [1] 46 46 |
79 | Melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d | [2] Melarsoprol Melarsoprol, Nifurtimox | [2] D00832
D00832
,
D00833
| - | - | [1] 65 65 |
80 | METHOTREXATE - 20 MG/0.8 ML SOLUZIONE INIETTABILE 4 SIRINGHE PRERIEMPITE MONOUSO DA 1.25 ML | [1] Methotrexate Methotrexate | [1] D00142
D00142
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 96 96 |
81 | Methylphenidate modified release 20 mg | [1] Methylphenidate Methylphenidate | [1] D04999
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
82 | MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - F | [1] Plerixafor Plerixafor | [1] D08971
D08971
| [1] CXCR4 CXCR4 💬 | [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 19 19 |
83 | MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) - 24 MG/1.2 ML 1 FLACONCINO | [1] Plerixafor Plerixafor | [1] D08971
D08971
| [1] CXCR4 CXCR4 💬 | [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 65 65 |
84 | Nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d | [2] Eflornithine Eflornithine, Nifurtimox | [2] D00833
D00833
,
D07883
| [1] ODC1 ODC1 💬 | [3] Arginine and proline metabolism Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬 | [1] 65 65 |
85 | Omaveloxolone Capsules, 20 mg | [1] Omaveloxolone Omaveloxolone | [1] D10964
D10964
| [1] NFE2L2 NFE2L2 💬 | [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 |
86 | OsrhAAT 20 mg/kg IV | - | - | - | - | [1] 231 231 |
87 | OTEZLA - 10 MG + 20 MG + 30 MG COMPRESSA RIVESTITA CON FILM USO ORALE - BLISTER (PVC/ALU) IN UN ASTUCCIO - 4 COMPRESSE DA 10 MG + 4 COMPRESSE DA 20 MG +19 COMPRESSE DA 30 MG | [1] Apremilast Apremilast | [1] D08860
D08860
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [2] 56 56, 107 |
88 | OXN 20 mg / 10 mg PR | - | - | - | - | [1] 6 6 |
89 | Oxycodone/naloxone prolonged release tablets 20 mg /10 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] D05312
D05312
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
90 | Pantoprazolo 20 mg gastro-resistant tablets | - | - | - | - | [1] 65 65 |
91 | Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP | [2] Paroxetine Paroxetine, Prednisolone | [2] D00472
D00472
,
D02362
| [2] NR3C1 NR3C1, SLC6A4 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 46 46 |
92 | Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP | [2] Paroxetine Paroxetine, Prednisolone | [2] D00472
D00472
,
D02362
| [2] NR3C1 NR3C1, SLC6A4 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 46 46 |
93 | PF-06650833 20 mg | [1] PF-06650833 PF-06650833 | - | - | - | [1] 46 46 |
94 | Plenadren 20 mg modified-release tablets | [2] Hydrocortisone Hydrocortisone, Manganese citrate | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 78 78 |
95 | Plovamer acetate 20 mg | [1] Acetate Acetate | - | - | - | [1] 13 13 |
96 | PN 200 tablets (500 mg naproxen and 20 mg omeprazole) | [2] Naproxen Naproxen, Omeprazole (Synonym: Omeprazole 20 mg) | [2] D00118
D00118
,
D00455
| [4] ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬 | [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 46 46, 271 |
97 | Ponesimod 20 mg | [1] Ponesimod Ponesimod | [1] D11215
D11215
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
98 | Prednisolon 20 mg JENAPHARM | - | - | - | - | [1] 41 41 |
99 | Prednisolone 20 mg | [1] Prednisolone Prednisolone | [1] D00472
D00472
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
100 | Prednison acis® 20 mg | - | - | - | - | [2] 43 43, 44 |
101 | Prednison acis¿ 20 mg | - | - | - | - | [2] 43 43, 44 |
102 | PTC518 tablet 20 mg | - | - | - | - | [1] 8 8 |
103 | Revatio 20 mg | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 85 85 |
104 | Revatio 20 mg film coated tablets | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
105 | Revatio 20 mg film-coated tablets | - | - | - | - | [1] 86 86 |
106 | Revatio 20 mg Filmtabletten | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
107 | REVATIO 20 mg, comprimidos recubiertos con película | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
108 | Revatio ® 20 mg film-coated tablets | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
109 | Rivaroxaban 20 mg | [1] Rivaroxaban Rivaroxaban | [1] D07086
D07086
| [1] F10 F10 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 91 91 |
110 | ROACTEMRA - 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
111 | RoActemra 20 mg/ml concentrado para solución para perfusión | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
112 | RoActemra 20 mg/ml Concentrate for solution for infusion | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
113 | RoActemra 20 mg/ml concentrate for solution for infusion. | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
114 | ROACTEMRA 20 mg/ml, concentrado para solución para perfusión | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [3] 46 46, 107, 271 |
115 | Sandostatin LAR 20 mg | [1] Octreotide Octreotide | [1] D00442
D00442
| [1] SSTR2 SSTR2 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 227 227 |
116 | SANDOSTATINA - LAR 20 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI | - | - | - | - | [1] 67 67 |
117 | Sildenafil (Revatio) 20 mg TID | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
118 | Sildenafil 20 mg tablets | [1] Sildenafil Sildenafil | [1] D08514
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 278 278 |
119 | Simvastatin 20 mg | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 46 46 |
120 | SOM230 LAR, 20 mg | - | - | - | - | [1] 75 75 |
121 | Tadalafil 20 MG | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 113 113 |
122 | Tadalafil 20 mg film-coated tablets | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
123 | Tafamidis meglumine 20 mg soft gelatin capsules | [3] Gelatin Gelatin, Meglumine, Tafamidis | [4] D00115
D00115
,
D01796
,
D06892
,
D09673
| [1] TTR TTR 💬 | [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 |
124 | Targinact 20 mg/10 mg prolonged-release tablets | [1] Manganese citrate Manganese citrate | - | - | - | [1] 6 6 |
125 | TPI-287 20 mg/m2 | [1] TPI-287 TPI-287 | - | - | - | [2] 5 5, 7 |
126 | Triamcinolone Hexacetonide 20 MG/ML | [1] Triamcinolone Triamcinolone | [1] D00385
D00385
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 107 107 |